In the same study, the authors observed that CCL18 increases the levels of miR-760 in exosomes, which activates an ARF6/Src/PI3K/AKT signaling cascade and induces BC cell proliferation, migration, invasion, and drug resistance. The gene discussed is AKT1; the disease is breast cancer.